MNKD Q1 2023 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$813M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$41M+238.8% YoY

Gross Profit

$24M60.1% margin

Operating Income

-$6M-14.8% margin

Net Income

-$10M-24.1% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

+12.7%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

-$7M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$298M

Total Liabilities

$554M

Stockholders' Equity

-$255M

Cash & Equivalents

$86M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$12M	+238.8%
Gross Profit	$24M	$994,000	+2356.0%
Operating Income	-$6M	-$21M	+71.8%
Net Income	-$10M	-$26M	+62.3%

Revenue Segments

License And Service

$11M100%